Cite
HARVARD Citation
Bredemeier, M. (2018). Mounting Evidence Indicates That Escalating Doses of Allopurinol Are Unnecessary for Cardiovascular Protection: Comment on the Article by Coburn et al. Arthritis & rheumatology. 70 (10), pp. 1696-1697. [Online].